US SB2443 | 2015-2016 | 114th Congress
Status
Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on January 12 2016 - 25% progression, died in committee
Action: 2016-01-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 12 2016 - 25% progression, died in committee
Action: 2016-01-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Advancing Standards in Regenerative Medicine Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.
Title
Advancing Standards in Regenerative Medicine Act
Sponsors
| Sen. Tammy Baldwin [D-WI] |
History
| Date | Chamber | Action |
|---|---|---|
| 2016-01-12 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB4669 (Same As) 2016-03-04 - Referred to the Subcommittee on Health.
Subjects
Cell biology and embryology
Drug safety, medical device, and laboratory regulation
Genetics
Health
Medical research
Organ and tissue donation and transplantation
Public-private cooperation
Drug safety, medical device, and laboratory regulation
Genetics
Health
Medical research
Organ and tissue donation and transplantation
Public-private cooperation
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/senate-bill/2443/all-info |
| Text | https://www.congress.gov/114/bills/s2443/BILLS-114s2443is.pdf |
